From: Carol S Wood
Sent: March 19, 2016
To: rule-comments@sec.gov
Subject: RE: Disclosure Effectiveness Review

As an older person, I take a couple of very expensive drugs. I am concerned that Medicare's inability to negotiate for lower drug prices is affecting my well-being. This is but one example of how I am affected by the political spending of companies and industries. If shareholders knew about this political funding and how it affects them, they might have something to say about it.

The SEC and its commissioners should continue to work on a rule requiring political disclosure from public companies, in the interests of their shareholders. Businesses should not be empowered to use backdoor political channels like nonprofits or associations to do their political bidding, and shareholders have a right to know how executives are using company resources for political purposes — especially if those purposes are against shareholders' interests.

Carol S Wood

Roanoke, TX